Drug Information

We offer data on over 11,000 brand and generic drugs.

NOTE: The information presented herein is not intended to serve as a substitute for a doctor's expertise.

Please consult a professional before starting to use any drug.

Teriparatide Subcutane. - Teriparatide - Injection Generic Drug

General Information

Read the Medication Guide provided by your pharmacist.
If you have any questions regarding the information, ask your doctor or pharmacist.
This medication is provided in a pen device for injection of the drug.
A manual is provided with instructions on the proper way to prepare and inject this drug.
Ask your doctor, nurse, or pharmacist any questions you may have about giving yourself shots.
Inject this medication under the skin (subcutaneously) into the thigh or abdominal wall usually as a single daily dose or as directed by your doctor.
Use a new needle with each dose.
Learn how to store and discard needles properly.
Some patients get dizzy or get a fast heartbeat after the first few doses of teriparatide.
For the first few doses, inject this medication where you can sit or lie down right away if you get dizzy or have a fast heartbeat.
Before using, check this product visually for particles or discoloration.
If present, do not use the liquid.
Use this medication regularly in order to get the most benefit from it.
To help you remember, use it at the same time each day.

This medication is used in women after menopause and in men to treat bone weakening (osteoporosis).
It is used in patients who are at high risk of having fractures, have had fractures, or who cannot use other osteoporosis treatments.
Teriparatide is a man-made (synthetic) form of the active part of a natural hormone called parathyroid hormone.
It acts by increasing bone mass and bone strength, thereby decreasing the chance of getting a fracture.

If overdose is suspected, contact your local poison control center or emergency room immediately.
Symptoms of overdose may include.

Refrigerate between 36 and 46 degrees F (2-8 degrees C) away from light and moisture.
This medication may be injected immediately after removing from the refrigerator.
Recap the pen when not in use.
Do not freeze.
Do not use this medication if it has been frozen.
Each pen may be used for up to 28 days after the first injection.
After 28 days of use, discard the pen, even if it still contains unused solution.
Keep all medicines away from children and pets.

If you miss a dose, use it as soon as you remember.
If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule.
Do not double the dose to catch up.

Learn about other means of preventing bone loss including taking regular calcium and/or vitamin D supplements, weight-bearing exercise, quitting smoking, and limiting alcohol intake.
Do not share this medication with others.
Laboratory and/or medical tests (for example, calcium) should be performed periodically to monitor your progress or check for side effects.
Consult your doctor for more details.

Dizziness or leg cramps may occur.
If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Tell your doctor immediately if any of these serious side effects occur.

Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription products you may use, especially of.

This medication has been shown to increase the rate of bone tumors (osteosarcoma) in animal (rat) studies.
This occurred at doses higher than the normal human dose of teriparatide.
Because it is unknown if this means there is a higher risk of bone tumors in humans, teriparatide should only be used in patients for whom the potential benefit outweighs the potential risk.
Teriparatide should not be used in patients at an increased risk of developing this type of tumor (for example, patients with Paget's disease, unexplained elevations of alkaline phosphatase, open epiphyses, or prior radiation therapy involving the skeleton).